Name: Treace Medical Concepts, Inc. (TMCI) Financial Statements
Creator: FinSpry

Treace Medical Concepts Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Treace Medical Concepts, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	209.36	187.12	141.84	94.42	57.37
Cost of Revenue	41.09	35.18	25.53	17.83	12.47
Gross Profit	168.26	151.94	116.31	76.59	44.90
Operating Expenses
Research & Development	20.54	15.44	13.58	10.20	5.85
Selling, General & Administrative	201.26	187.93	137.57	82.90	38.19
Operating Expenses	223.90	203.37	151.15	93.10	44.04
Operating Income	-55.64	-51.43	-34.84	-16.51	0.86
Other Income/Expense
Interest Income	4.88	6.73	1.31	0.02	0.00
Interest Expense	-5.26	5.17	-4.40	-4.06	-2.78
Other Income/Expense	0.32	-6.92	-0.06	-0.02	-1.75
Income
Income Before Tax	-55.74	-49.34	-42.82	-20.55	-3.67
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-55.74	-49.53	-42.82	-20.55	-3.67
Net Income - Continuous Operations	-55.74	-49.53	-42.82	-20.55	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-48.22	-38.71	-32.71	-15.61	2.07
EBIT	-55.64	-44.36	-34.84	-16.49	0.86
Depreciation & Amortization	7.42	5.35	2.13	0.69	1.21
Earnings Per Share
Basic EPS	-1.00	-1.00	-1.00	-	-
Diluted EPS	-1.00	-1.00	-1.00	-	-
Basic Shares Outstanding	62.11	60.85	55.28	48.42	37.07
Diluted Shares Outstanding	62.11	60.85	55.28	48.42	37.07